The disease‐linked R336C mutation in cystathionine β‐synthase disrupts communication with the PLP cofactor, yet maintains the enzyme's overall structural integrity
The FEBS Journal · 2025
DOI: 10.1111/febs.70116 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Carolina Conter und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain. Hauptthemen laut MEDLINE: Cystathionine beta-Synthase, Pyridoxal Phosphate, Homocystinuria. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Diputación Foral de Bizkaia, Osasun Saila, Eusko Jaurlaritzako, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Cystathionine β‐synthase (CBS) is a pyridoxal‐phosphate (PLP)‐dependent enzyme essential for the reverse transsulfuration pathway, where homocysteine and serine combine to form cystathionine, the immediate precursor of cysteine. Mutations in the CBS gene cause homocystinuria, a disorder associated with intellectual disability, multisystem complications, and reduced life expectancy. The CBS p.R336C mutation, linked to severe pyridoxine non‐responsiveness, results in reduced enzyme activity, previously attributed to protein instability and weakened substrate and PLP binding. To clarify the effects of the pathological R336C mutation, we performed biochemical, biophysical, and crystallographic analyses, as well as molecular dynamics simulations. Our findings show that the R336C mutation minimally impacts the structural environment around residue 336, does not cause enzyme misfolding, and does not impair the binding of PLP or the allosteric activator S‐adenosylmethionine (AdoMet) binding. Instead, the mutation induces subtle reorientations in nearby hydrophobic residues, including F185 and Y381, altering intramolecular contacts that perturb the interaction between asparagine 149 and the O3 oxygen of PLP. This alteration is known to potentially shift the tautomeric equilibrium of the PLP Schiff base from its catalytically active ketoenamine form to the inactive enolimine form, which aligns with the reduced activity of the R336C variant. Additionally, the R336C mutation disrupts intermolecular contacts between the catalytic core and Bateman module, altering the Bateman module's intrinsic mobility in the enzyme's basal state and potentially affecting the cavity opening required for catalysis. Importantly, the R336C variant retains the native enzyme's ability to assemble into polymeric chains in crystals, preserving its filament formation capacity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
- College of Medicine, QU Health, Qatar University, Doha, Qatar.
- Biomedical Research Center, Qatar University, Doha, Qatar.
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
- Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
- Department of Biotechnology, University of Verona, Italy.
ORCID-Profile: Carolina Conter, Gonzalo Jiménez-Osés, Luis Alfonso Martínez-Cruz
Förderung
- Diputación Foral de Bizkaia
- Osasun Saila, Eusko Jaurlaritzako
- Instituto de Salud Carlos III
- Fundación Científica Asociación Española contra el cancer
- 'la Caixa' Foundation
- Ministero dell'Università e della Ricerca
- Ministerio de Ciencia e Innovación (MICINN)
Zitieren
APA
Conter, C., Núñez-Franco, R., Al-Sadeq, D. W., Fernández-Rodríguez, C., Goikoetxea-Usandizaga, N., Nasrallah, G. K., Nomikos, M., Martinez-Chantar, M. L., Astegno, A., Jiménez-Osés, G., & Martínez-Cruz, L. A. (2025). The disease‐linked R336C mutation in cystathionine β‐synthase disrupts communication with the PLP cofactor, yet maintains the enzyme's overall structural integrity. The FEBS Journal. https://doi.org/10.1111/febs.70116
Vancouver
Conter C, Núñez-Franco R, Al-Sadeq DW, Fernández-Rodríguez C, Goikoetxea-Usandizaga N, Nasrallah GK, et al. The disease‐linked R336C mutation in cystathionine β‐synthase disrupts communication with the PLP cofactor, yet maintains the enzyme's overall structural integrity. The FEBS Journal. 2025. doi:10.1111/febs.70116
BibTeX
@article{Conter2025,
author = {Conter, Carolina and Núñez-Franco, Reyes and Al-Sadeq, Duaa Walid and Fernández-Rodríguez, Carmen and Goikoetxea-Usandizaga, Naroa and Nasrallah, Gheyath K and Nomikos, Michail and Martinez-Chantar, Maria Luz and Astegno, Alessandra and Jiménez-Osés, Gonzalo and Martínez-Cruz, Luis Alfonso},
title = {The disease‐linked R336C mutation in cystathionine β‐synthase disrupts communication with the PLP cofactor, yet maintains the enzyme's overall structural integrity},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.70116}
}
EUVIMED